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About the Palliative Care Outcomes Collaboration (PCOC)  
 
 
PCOC is a unique national program that utilises standardised validated clinical assessment tools to benchmark and measure outcomes in palliative care. Participation in 
PCOC is voluntary and enables palliative care service providers to improve practice and meet the Palliative Care Australia (PCA) Standards for Providing Quality Palliative 
Care for all Australians. PCOC is funded under the National Palliative Care Program and is supported by the Australian Government Department of Health and Ageing. 
 
PCOC is a collaboration between four centres, each with a Chief Investigator, and is divided into four zones for the purpose of engaging with palliative care service 
providers.  The four PCOC zones and their Chief Investigators are: 
 
    Central Zone    Professor Kathy Eagar, Australian Health Services Research Institute, University of Wollongong  
 
West Zone         Assistant Professor Claire Johnson, Cancer and Palliative Care Research and Evaluation Unit, University of WA 
South Zone        Professor David Currow, Department of Palliative and Supportive Services, Flinders University 
    North Zone        Professor Patsy Yates, Institute of Health and Biomedical Innovation, Queensland University of Technology 
 
The National office is located within the Australian Health Services Research Institute at the University of Wollongong. 
 
 
The items included in the PCOC dataset (Version 2) serve the dual purpose of: 
 
• Defining a common clinical language to allow communication between palliative care providers 
• Facilitating the routine collection of National palliative care data for the purpose of reporting and benchmarking to drive quality improvement 
The dataset includes the clinical assessment tools: Phase of Care, Palliative Care Problem Severity Score (PCPSS), Symptom Assessment Scale (SAS), Australia-modified 
Karnofsky Performance Status Scale (AKPS) and Resource Utilisation Groups – Activities of Daily Living (RUG-ADL). These are used as indicators of the quality and 
outcomes of palliative care. For more information on the PCOC clinical tools or data items please visit www.pcoc.org.au
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Introduction 
 
PCOC aims to assist services to improve the quality of the palliative care they provide through the analysis and benchmarking of patient outcomes. In this, the eleventh 
PCOC report, data submitted for the January – June 2011 period are summarised and patient outcomes benchmarked to enable participating services to assess their 
performance and identify areas in which they may improve. 
 
This report is broken into three sections: 
 
Section 1 summarises each of the four benchmark measures and presents national benchmarking results for selected benchmarks 
Section 2 presents additional analysis for each of the four benchmark measures 
Section 3 provides descriptive analysis of the data items at each of the patient, episode and phase levels 
 
In each of the three sections, data and analysis for VIC is presented alongside the national figures for comparative purposes. The national figures reflect all palliative care 
services who submitted data for the January – June 2011 period. A full list of these services can be found at www.pcoc.org.au 
 
If you would like more information regarding this report please contact: 
Wendy Gain 
PCOC National Director 
Email: wgain@uow.edu.au  
Phone: (02) 4221 5093 
 
   
“PCOC is an excellent example of a national and voluntary programme using benchmarking to measure outcomes in palliative care” 
PRISMA (Reflecting the Positive DiveRsities of European PrIorities for ReSearch and Measurement in End-of-Life CAre) in their recent publication 
Outcome Measurement in Palliative Care – The Essentials, www.prismafp7.eu 
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Section 1 – Victoria at a Glance 
 
Table 1   Summary of benchmark measures 1-3 
Measure Description Benchmark Overnight admitted Not admitted overnight 
   VIC  Score Benchmark Met? VIC Score Benchmark Met? 
1. Time from referral to contact Patients contacted on same or following day 90% 84.9 No 45.4 No 
2. Time in unstable phase 
  
  
Patients unstable less than 7 days - first phase 85% 85.5 Yes 64.1 No 
Patients unstable less than 7 days - Not first phase 90% 90.4 Yes 66.8 No 
Median time in unstable phase 2 days or less 2 days Yes 3 days No 
3. Change in pain 
PC Problem Severity Score 
(PCPSS) 
 
 
Symptom Assessment Score 
(SAS) 
Patients with absent/mild pain at phase start 
remaining absent/mild at phase end 
90% 81.9 No  74.6 No 
Patients with moderate/severe pain at phase start 
with absent/mild at phase end 
60% 53.9 No  58.7 No 
Patients with absent/mild pain at phase start 
remaining absent/mild at phase end 
90% 80.4 No  76.8 No 
Patients with moderate/severe pain at phase start 
with absent/mild at phase end 
60% 52.9 No  63.6 Yes 
 
Table 2   Summary of benchmark measure 4: Change in symptoms relative to the national average (X-CAS) 
 
 
For more information on the 
benchmark measures, see 
Section 2 and Appendix B 
 
 
Clinical Tool Symptom Benchmark VIC score Benchmark met? 
PC PSS 
  
  
  
Pain 0 or above 0.12 Yes 
Other symptoms 0 or above 0.28 Yes 
Family/carer 0 or above 0.13 Yes 
Psychological/spiritual 0 or above 0.13 Yes 
SAS 
  
  
  
Pain 0 or above 0.20 Yes 
Nausea 0 or above 0.20 Yes 
Breathing 0 or above 0.29 Yes 
Bowels 0 or above 0.35 Yes 
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Section 2 – Benchmark Analysis 
 
Measure 1 - Time from referral to first contact 
 
Time from referral to first contact was selected as a benchmark measure as it reports responsiveness of palliative care services to patient needs.  This benchmark was set 
acknowledging there is wide variation in delivery of palliative care service provision across the country.  It was agreed at the 2008 national benchmarking workshops that 
access to palliative care service should be based on patient need rather than service availability.  In other words services operating a 5 day week (Monday-Friday) are 
benchmarked against services operating 7 days a week. 
Table 3 and Figure 1 below present descriptive data on the first benchmark measure. This measure is the percentage of patients seen either on the day of, or the day 
following the referral. The benchmark is 90%. 
 
The time from referral to first contact is calculated as the time from the date of referral to either the date of first contact (if provided) or the episode start date.  
 
Table 3   Time from referral to first contact by episode type 
Time (in days) Overnight admitted Not admitted overnight 
VIC % All Services % VIC % All Services % 
Same day or following day     1556     84.9     9127     89.6     1514     45.4     3058     52.1 
2-7 days      224     12.2      878      8.6     1145     34.4     1856     31.6 
8-14 days       28      1.5      110      1.1      391     11.7      560      9.5 
Greater than 14 days       24      1.3       74      0.7      282      8.5      395      6.7 
Average      1.5 na      1.3 na      3.3 na      2.9 na 
Median        1 na        1 na        2 na        1 na 
Note: Episodes where referral date was not recorded are excluded from the table. In addition, all records where time from referral to first contact or time from first contact to episode start was greater than 7 
days were considered to be outliers and were assumed to equal 7 days for the purpose of calculating the average and median time. 
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Figure 1     Time from referral to first contact 
 
Overnight admitted episodes for VIC Overnight admitted episodes for all services 
  
 
Not admitted overnight episodes for VIC 
 
Not admitted overnight episodes for all services 
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Measure 2 - Time in unstable phase 
 
The unstable phase, by nature of its definition, alerts clinical staff to the need for urgent or emergency intervention.  This phase shows the effectiveness of the 
intervention(s) implemented for a specific new or exacerbation of existing problem.  Those patients determined as being in the unstable phase require intense review for 
a short period of time.  This period of time was considered less than 7 days – that is, any patient who is deemed unstable should have their problem(s) managed and 
under control within this period of time regardless of the setting of care. 
The following table presents descriptive data on the second benchmark measure. The first part of this measure is the percentage of patients remaining unstable for less 
than 7 days and is split by occurrence of unstable phase. The benchmark for patients in their first phase is 85% and for patients in a subsequent phase is 90%. The second 
part of this measure is the median time spent in the unstable phase and the benchmark is 2 days or less.  
 
 
Table 4   Time in unstable phase by episode type and occurrence of unstable phase 
Episode type Occurrence of 
unstable phase 
Number Percent unstable for < 7 days Median days in unstable phase 
 VIC All Services VIC All Services VIC All Services 
Overnight admitted First phase        739  5088     85.5     79.8  2  3 
Subsequent phase   623  2461     90.4     86.4  2  2 
Total             1362  7549     87.7     82.0  2  3 
Not admitted overnight First phase        488   847     64.1     59.6  4  4 
Subsequent phase   675  1146     66.8     67.8  3  3 
Total             1163  1993     65.7     64.3  3  3 
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Measure 3 - Change in pain 
 
The management of patients with pain is acknowledged as core business for palliative care services.  Hence measuring the distress from pain was agreed at the 2008 
National Benchmarking workshops as an important outcome for palliative care services.  Two of the five assessment tools used in PCOC are used to measure pain, the 
Symptom Assessment Score (SAS) is a patient rated tool and the palliative Care Problem Severity Score (PCPSS) is a clinician rated tool.  At the 2008 benchmarking 
workshops it was agreed that the outcomes for pain are at 2 levels: Patients with absent/mild pain at phase start and patients with moderate/severe pain at phase start. 
 
Change in pain - PC Problem Severity Score (PCPSS) 
 
The following two tables present data on the third benchmark measure in relation to pain PCPSS. The first measure is the percentage of patients with absent/mild pain 
at phase start remaining with absent/mild pain at phase end and the benchmark is 90%. The second measure is the percentage of patients with moderate/severe pain at 
phase start with absent/mild pain at phase end and the benchmark is 60%. Note that only phases with a valid pain score at both the start and the end of the phase are 
included in the following analysis.  
 
 
Table 5   Patients with absent or mild pain at beginning of phase whose pain remained absent or mild at end of phase 
Episode type  VIC All Services 
 Report 8 Report 9 Report 10 Report 11 Report 8 Report 9 Report 10 Report 11 
Overnight 
admitted 
Number      630      771     1079     1660     2166     2860     3969     5153     
%     75.5     78.9     79.5     81.9     75.9     79.0     79.0     82.1     
Not admitted 
overnight 
Number      515      554     1310     1383     1336     1441     2415     2176     
%     76.6     77.4     75.0     74.6     77.1     75.8     74.9     75.1 
 
Table 6   Patients with moderate or severe pain at beginning of phase whose pain decreased to absent or mild at end of phase 
Episode type  VIC All Services 
 Report 8 Report 9 Report 10 Report 11 Report 8 Report 9 Report 10 Report 11 
Overnight 
admitted 
Number      234      257      351      456     1031     1257     1655     1858     
%     52.9     56.0     59.2     53.9     40.8     44.0     46.6     48.0     
Not admitted 
overnight 
Number      148      199      455      431      382      485      806      646     
%     56.9     61.8     58.9     58.7     54.0     55.7     57.5     57.3 
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Change in pain - Symptom Assessment Score (SAS) 
 
The following two tables present data on the third benchmark measure in relation to pain SAS. The first measure is the percentage of patients who commenced with 
absent/mild pain at phase start and have absent/mild pain at phase end and the benchmark is 90%. The second measure is the percentage of patients with 
moderate/severe pain at phase start with absent/mild pain at phase end and the benchmark is 60%. Note that only phases with a valid pain score at both the start and 
the end of the phase are included in the following analysis.  
 
 
Table 7   Patients with absent or mild pain at beginning of phase whose pain remained absent or mild at end of phase 
Episode type  VIC All Services 
 Report 8 Report 9 Report 10 Report 11 Report 8 Report 9 Report 10 Report 11 
Overnight 
admitted 
Number      649      728      894     1460     2950     3370     4672     5902     
%     78.9     80.5     79.0     80.4     76.7     79.8     78.8     81.8     
Not admitted 
overnight 
Number      486      511     1308     1467     2008     1978     2825     2566     
%     72.1     77.5     75.3     76.8     76.8     78.2     76.4     76.8 
 
 
Table 8   Patients with moderate or severe pain at beginning of phase whose pain decreased to absent or mild at end of phase 
Episode type  VIC All Services 
 Report 8 Report 9 Report 10 Report 11 Report 8 Report 9 Report 10 Report 11 
Overnight 
admitted 
Number      199      185      218      409     1339     1453     1912     2159     
%     46.8     51.2     51.9     52.9     41.0     41.3     45.7     46.4     
Not admitted 
overnight 
Number      177      158      408      411      598      591      846      708     
%     60.0     60.5     60.4     63.6     50.1     53.1     55.3     57.0 
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Figure 2     Change in pain benchmark measures - all phases 
 
 Pain PCPSS  Pain PCPSS 
  
 Absent/mild pain at both start and end of phase 
  
 Pain SAS 
 Mod/severe pain at start with absent/mild pain at end 
  
 Pain SAS 
  
 Absent/mild pain at both start and end of phase  Mod/severe pain at start with absent/mild pain at end 
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Measure 4 – Change in symptoms relative to the baseline national average (X-CAS) 
 
Measure 4 includes a suite of case-mix adjusted scores used to compare the change in symptoms for similar patients i.e. patients in the same phase who started with the 
same level of symptom. Eight symptoms are included this report: 
 
1. PCPSS Pain 2. PCPSS Other symptoms 3. PCPSS Psychological/spiritual 4. PCPSS Family/carer 
5. SAS Pain 6. SAS Nausea 7. SAS Bowels 8. SAS Breathing 
 
The suite of benchmarks included in Measure 4 are generally referred to as X-CAS
 
 – CAS standing for Case-mix Adjusted Score, and the X to represent that multiple 
symptoms are included. 
 
 
 
 
How to interpret X-CAS: 
 
The X-CAS benchmarks are calculated relative to a baseline reference period (currently July-December 2008). As a result: 
 
If X-CAS is greater than 0 then on average, the patients’ change in symptom was better than similar patients
If X-CAS is 
 in the baseline reference period.  
equal to 0 then on average, the patients’ change in symptom was about the same as similar patients
If X-CAS is 
 in the baseline reference period. 
less than 0 then on average, the patients’ change in symptom was worse than similar patients
 
 in the baseline reference period. 
As the X-CAS measures look at change in symptom, they are only able to be calculated on phases which ended in phase change or discharge (as the phase end scores are 
required to determine the change). Bereavement phases are excluded from the analysis.  
 
A more technical explanation of X-CAS is included in Appendix B. 
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Figure 3     PCPSS mean change adjusted for phase and symptom score at start of phase 
 
 
 Pain  Other symptoms 
  
 Family/Carer  Psychological/spiritual 
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Figure 4     SAS mean change adjusted for phase and symptom score at start of phase 
 
 
 Pain  Nausea 
  
  
 Breathing 
  
 Bowels 
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Section 3 - Descriptive analysis 
 
There are three levels of PCOC data items – Patient, Episode and Phase. 
 
The broad detail is found at the patient level, where the data items look at patient demographics. 
 
At the episode level, the items focus on characterising each setting of palliative care. They also describe the reasons behind why and how palliative care episodes 
start/end, the level of support patients receive both before and after an episode and (where applicable) the setting in which the patient died.  
 
The clinical focus of PCOC is at the phase level. The items at this level describe the patient’s stage of illness, functional impairment as well as their levels of pain and 
symptom distress. The items at the phase level are used to quantify patient outcomes, and are the focus of the PCOC Benchmarks in the previous sections. 
 
This section provides an overview of the data submitted by VIC services at each level for the current reporting period. Summaries of the national data are included for 
comparative purposes. 
 
 
 
 
 
 
  
Some tables throughout this section may be incomplete. This is because some items may not be applicable to a particular service or it may be due to data 
quality issues. 
 
Please use the following key when interpreting the tables: 
 
na   The item is not applicable 
u     The item was unavailable/unable to be calculated due to missing or invalid data. 
 
In addition, interpret all figures carefully as results may appear distorted due to low frequencies being represented as percentages. 
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Profile of palliative care patients 
 
The information collected on each patient includes Indigenous status, sex, main language spoken at home and country of birth.  Table 9 shows the Indigenous status for 
all patients for VIC and nationally.  Non-disclosure of Indigenous status can result in cultural issues not being identified. A number of programs exist that can assist 
services to encourage Indigenous persons to identify.      
 
Table 9   Indigenous Status - all patients 
Indigenous Status VIC All Services 
Aboriginal but not Torres Strait Islander origin       27      141 
Torres Strait Islander but not Aboriginal origin       11       25 
Both Aboriginal and Torres Strait Islander origin        6       17 
Neither Aboriginal nor Torres Strait Islander origin     3871    12982 
Not stated/inadequately described      346      720 
Total     4261    13885 
 
 
Table 10 shows a breakdown of malignant and non-malignant diagnosis for the patients for VIC and at the national level.  The development of Version 3 Data Set will 
include further opportunity to expand on diagnosis for both malignant and non-malignant categories.   
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Table 10   Primary diagnosis 
Primary diagnosis  VIC % All Services % 
Malignant                         Bone and soft tissue                  97 2.8    215 1.9 
Breast                               286 8.2    883 7.7 
CNS                                   67 1.9    196 1.7 
Colorectal                           424 12.1  1260 11.0 
Gynaecological                       168 4.8    546 4.8 
Haematological                       215 6.2    607 5.3 
Head and neck                        230 6.6    656 5.7 
Lung                                 715 20.5  2245 19.6 
Pancreas                             204 5.8    619 5.4 
Prostate                             235 6.7    764 6.7 
Skin                                 117 3.4    429 3.8 
Other GIT                            318 9.1    965 8.4 
Other urological                     135 3.9    453 4.0 
Other malignancy                     187 5.4    604 5.3 
Unknown primary                       94 2.7    328 2.9 
Malignant - not further defined        0 0.0    662 5.8 
All malignant 3492 100.0  11432 100.0 
Non-malignant                     Cardiovascular                       145 19.4   440 20.0 
HIV/AIDS                               3 0.4      9 0.4 
Kidney failure                        95 12.7   285 13.0 
Neurological disease                 175 23.4   491 22.4 
Respiratory failure                  117 15.6   322 14.7 
Other non-malignancy                 214 28.6   567 25.8 
Non-malignant - not further defined    0 0.0     82 3.7 
All non-malignant  749 100.0   2196 100.0 
Note: All patients where diagnosis was not stated/inadequately described are excluded from the table. 
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Profile of palliative care episodes 
 
An episode of care is a period of contact between a patient and a palliative care service that is provided by one palliative care service and occurs in one setting – for the 
purposes of this report, either as an overnight admitted patient or not admitted overnight patient.  
 
An episode of care refers to the care received within one setting. An episode of palliative care begins on the day the patient is assessed face to face by the palliative care 
provider and there is agreement between the patient and the service. 
 
An episode of palliative care ends when: 
 
• the principal clinical intent of the care changes and the patient is no longer receiving palliative care 
• the patient is formally separated from the hospital/hospice/community or, 
• the patient dies 
 
Referral source refers to the service or organisation from which the patient was referred to for each individual episode of care. Table 11 presents referral source by 
episode type.  Review of referral source can identify opportunities to connect with referral sources that are currently lower than the national referral profile (e.g. a 
community service with few GP referrals may want to re-address referral or triage practices and look to working more collaboratively). 
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Table 11   Referral source by episode type 
Referral source Overnight admitted Not admitted overnight 
VIC % All Services % VIC % All Services % 
Public hospital - other than inpatient palliative care unit      795     43.2     4741     45.2     1754     52.6     3305     47.9 
Self, carer(s), family or friends        7      0.4      315      3.0      121      3.6      227      3.3 
Private hospital - other than inpatient palliative care unit      193     10.5      714      6.8      507     15.2      862     12.5 
Public palliative care inpatient unit/hospice       10      0.5      306      2.9       46      1.4      411      6.0 
Private palliative care inpatient unit/hospice        5      0.3       48      0.5       11      0.3       39      0.6 
General medical practitioner       26      1.4      620      5.9      217      6.5      847     12.3 
Specialist medical practitioner       32      1.7      332      3.2      101      3.0      366      5.3 
Community-based palliative care agency      436     23.7     2206     21.0       43      1.3       89      1.3 
Community-based service       66      3.6      393      3.7       85      2.5      185      2.7 
Residential aged care facility       13      0.7       83      0.8      148      4.4      184      2.7 
Other        5      0.3       88      0.8      119      3.6      174      2.5 
Not stated/inadequately described      251     13.6      654      6.2      182      5.5      205      3.0 
Total     1839    100.0    10500    100.0     3334    100.0     6894    100.0 
 
 
Table 12   Place of death - patients not admitted overnight 
Place of death VIC % All Services % 
Private residence      409 53.7         1055 56.9 
Residential aged care setting      200 26.2          288 15.5 
Other location*       94 12.3          345 18.6 
Not stated/inadequately described       59 7.7           165 8.9 
Total      762 100.0        1853 100.0 
* Includes patients who have died in a hospital setting without the episode of non-admitted palliative care being ended. Patients whose community  
  episode has  ended when admitted to hospital are excluded from this table. 
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Table 13 gives a summary of the length of episode for patients for VIC and nationally. 
Table 13   Length of episode summary 
Length of episode Overnight admitted Not admitted overnight 
VIC All Services VIC All Services 
Average length of episode     12.8     11.6     23.9     23.3 
Median length of episode      7.0      7.0     23.0     22.0 
Note: Bereavement phase records are excluded and episodes that remain open at the end of the reporting period (and hence do not have an episode end date), are also excluded. In addition, any records 
where LOS was greater than 90 days were considered to be outliers and are excluded from the average calculations. 
 
 
 
Table 14 details the length of episodes by number of days.  
  
 
Table 14   Length of episode breakdown 
Length of episode Overnight admitted Not admitted overnight 
VIC % All Services % VIC % All Services % 
Same day       72 4.0           367 3.6           246 7.7           535 8.3 
1-2 days      329 18.1         1902 18.5          255 8.0           506 7.9 
3-4 days      247 13.6         1387 13.5          145 4.6           305 4.7 
5-7 days      302 16.6         1730 16.8          217 6.8           459 7.1 
8-14 days      344 18.9         2167 21.1          371 11.7          788 12.2 
15-21 days      172 9.5          1079 10.5          312 9.8           610 9.5 
22-30 days      127 7.0           704 6.8           260 8.2           553 8.6 
31-60 days      159 8.7           718 7.0           504 15.9         1003 15.6 
61-90 days       48 2.6           158 1.5           283 8.9           552 8.6 
Greater than 90 days       20 1.1            74 0.7           584 18.4         1131 17.6 
Total     1820 100.0       10286 100.0        3177 100.0        6442 100.0 
Note: Bereavement phase records are excluded and episodes that remain open at the end of the reporting period (and hence do not have an episode end date), are also excluded. 
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Profile of palliative care phases 
 
The palliative care phase is the stage of the patient’s illness. Palliative care phases are not sequential and a patient may move back and forth between phases.  
Palliative care phases provide a clinical indication of the level of care required. There are five palliative care phases; stable, unstable, deteriorating, terminal and 
bereaved. 
 
 
 
Table 15   Number of phases by phase type and episode type 
Phase Overnight admitted Not admitted overnight 
VIC % All Services % VIC % All Services % 
Stable                                    1503 29.9             6914 26.1             2690 43.2             4338 36.6 
Unstable                                  1362 27.1             7549 28.5             1163 18.7             1993 16.8 
Deteriorating                             1129 22.5             6595 24.9             1926 30.9             4383 37.0 
Terminal                                   754 15.0             4084 15.4              429 6.9              1036 8.8 
Bereaved                                  275 5.5              1381 5.2                19 0.3                90 0.8 
All phases         5023 100.0           26523 100.0            6227 100.0           11840 100.0 
 
 
Table 16   Average phase length (in days) by phase and episode type 
Phase Overnight admitted Not admitted overnight 
VIC All Services VIC All Services 
Stable                            7.4      7.0      23.0         23.6 
Unstable                          3.5      4.3      7.0           8.6 
Deteriorating                     6.3      5.3      13.5         16.1 
Terminal                          2.0      2.2      2.8           2.9 
Bereaved                          1.3      1.1      1.3           2.1 
Note: Phase records where length of phase was greater than 90 days were considered to be outliers and are excluded from the average calculations. 
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Table 17   Profile of PC Problem Severity Scores at beginning of phase by phase type - overnight admitted (percentages) 
Phase Problem severity VIC All Services 
 Absent Mild Moderate Severe Absent Mild Moderate Severe 
Stable                            Pain                    51.0 31.7 14.5  2.8 43.0 37.5 15.5  4.0 
Other Symptom           22.9 51.2 22.3  3.5 20.2 42.7 27.3  9.8 
Psychological/Spiritual 29.2 51.9 16.6  2.3 24.7 45.9 21.8  7.6 
Family/Carer            47.1 35.1 14.2  3.5 33.4 37.9 19.9  8.9 
Unstable                          Pain                    34.4 25.8 26.8 12.9 25.2 27.6 30.5 16.6 
Other Symptom           10.1 32.9 44.6 12.4  8.1 24.4 41.8 25.7 
Psychological/Spiritual 16.3 41.4 33.2  9.0 13.9 34.9 34.8 16.4 
Family/Carer            33.1 32.1 25.4  9.5 21.0 31.0 30.5 17.6 
Deteriorating                     Pain                   42.3 30.0 19.8  7.8 30.7 32.4 26.3 10.6 
Other Symptom           11.8 35.3 39.1 13.8  9.2 26.2 40.0 24.6 
Psychological/Spiritual 23.7 39.9 25.6 10.8 17.3 35.9 30.5 16.2 
Family/Carer            34.3 30.3 24.1 11.3 21.1 30.2 30.1 18.6 
Terminal                          Pain                    40.8 26.0 21.7 11.5 38.2 28.4 21.9 11.6 
Other Symptom           20.6 27.7 31.8 19.9 21.0 22.5 28.9 27.5 
Psychological/Spiritual 40.1 27.8 21.3 10.8 35.3 26.5 21.5 16.6 
Family/Carer            18.3 22.3 34.1 25.2 15.0 24.8 31.8 28.4 
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Table 18   Profile of PC Problem Severity Scores at beginning of phase by phase type - not admitted overnight (percentages) 
Phase Problem severity VIC All Services 
 Absent Mild Moderate Severe Absent Mild Moderate Severe 
Stable                            Pain                    32.5 51.6 14.7  1.2 36.8 48.9 13.0  1.3 
Other Symptom           13.6 57.5 27.0  1.9 15.7 55.3 26.5  2.4 
Psychological/Spiritual 19.2 57.3 21.7  1.8 24.8 52.4 20.5  2.3 
Family/Carer            17.7 49.1 30.1  3.2 23.8 46.0 26.5  3.7 
Unstable                          Pain                    14.7 27.0 38.3 19.9 17.3 27.5 35.4 19.8 
Other Symptom            6.8 30.3 44.6 18.3  6.4 27.0 45.4 21.2 
Psychological/Spiritual 13.1 43.5 31.7 11.7 13.4 39.9 34.4 12.2 
Family/Carer            13.6 30.2 39.6 16.6 15.0 29.7 38.0 17.4 
Deteriorating                     Pain                   23.4 47.4 24.5  4.8 26.2 45.6 22.8  5.5 
Other Symptom            5.5 33.8 49.0 11.7  6.5 34.6 46.3 12.6 
Psychological/Spiritual 14.3 48.6 31.6  5.5 18.2 46.1 28.7  7.1 
Family/Carer             8.4 29.6 50.2 11.9 13.8 32.1 41.9 12.2 
Terminal                          Pain                    31.0 46.2 16.2  6.5 36.4 38.9 17.3  7.4 
Other Symptom           19.0 35.0 32.3 13.8 21.2 33.1 30.1 15.6 
Psychological/Spiritual 38.9 38.0 17.3  5.8 42.7 34.8 15.2  7.2 
Family/Carer             8.4 25.5 43.3 22.8 12.7 29.6 37.1 20.5 
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Figure 5     Total RUG-ADL at beginning of phase – overnight admitted patients 
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Figure 6     Total RUG-ADL at beginning of phase – patients not admitted overnight 
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RUG-ADL (shown on the previous two pages) consists of 4 items (bed mobility, toileting, transfers and eating) and should be assessed on admission, at phase change and 
at episode end. 
The Karnofsky Performance Status Scale used in PCOC is the Australia-modified version which is applicable to both inpatient and community palliative care. The 
Karnofsky Performance Scale assesses patient/client functioning and performance and can be used in determining prognosis /survival times. 
Karnofsky & RUG-ADL can be used together to provide a profile of both patient dependency, equipment requirements, need for allied health referrals and carer 
burden/respite requirements. 
 
Table 19   Karnofsky score at phase start by episode type 
Karnofsky score Overnight admitted Not admitted overnight 
VIC % All Services % VIC % All Services % 
Comatose or barely rousable      392      8.3     2298      9.2      219      3.5      453      3.9 
Totally bedfast and requiring extensive nursing care     1038     21.9     5020     20.0      515      8.3     1049      9.0 
Almost completely bedfast      565     11.9     2887     11.5      480      7.7      742      6.4 
In bed more than 50% of the time      826     17.5     4035     16.1      890     14.4     1473     12.6 
Requires considerable assistance      989     20.9     4837     19.3     1433     23.1     2626     22.5 
Requires occasional assistance      642     13.6     3311     13.2     1298     20.9     2651     22.7 
Cares for self      179      3.8     1003      4.0      784     12.6     1670     14.3 
Normal activity with effort       65      1.4      377      1.5      281      4.5      588      5.0 
Able to carry on normal activity; minor signs or symptoms       26      0.5      117      0.5       65      1.0      157      1.3 
Normal; no complaints; no evidence of disease        0      0.0        7      0.0        1      0.0        8      0.1 
Not stated/inadequately described       10      0.2     1165      4.6      236      3.8      265      2.3 
Total     4732    100.0    25057    100.0     6202    100.0    11682    100.0 
 
  
         
 
Outcomes in Palliative Care, Report 11 (January – June 2011) – Victoria                      32 
Table 20   How stable phases end 
Phase end reason Overnight admitted Not admitted overnight 
VIC % All Services % VIC % All Services % 
Phase change                       1003  66.7  3926  56.8  1993  74.1  2843  65.5 
Discharge/case closure              468  31.1  2841  41.1   596  22.2  1169  26.9 
Died                                 25   1.7   117   1.7   100   3.7   266   6.1 
Bereavement phase end                 5   0.3    10   0.1     0   0.0     1   0.0 
Not stated/inadequately described     2   0.1    20   0.3     1   0.0    59   1.4 
Total  1503 100.0  6914 100.0  2690 100.0  4338 100.0 
 
 
 
Figure 7     Stable phase progression - overnight admitted 
 
Figure 8     Stable phase progression -  not admitted overnight 
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Table 21   How unstable phases end 
Phase end reason Overnight admitted Not admitted overnight 
VIC % All Services % VIC % All Services % 
Phase change                       1188  87.2  6464  85.6   920  79.1  1406  70.5 
Discharge/case closure              100   7.3   721   9.6   208  17.9   462  23.2 
Died                                 67   4.9   345   4.6    34   2.9    89   4.5 
Bereavement phase end                 7   0.5    12   0.2     1   0.1     4   0.2 
Not stated/inadequately described     0   0.0     7   0.1     0   0.0    32   1.6 
Total  1362 100.0  7549 100.0  1163 100.0  1993 100.0 
 
 
 
Figure 9     Unstable phase progression - overnight admitted 
 
 
Figure 10   Unstable phase progression -  not admitted overnight 
 
  
 
  
         
 
Outcomes in Palliative Care, Report 11 (January – June 2011) – Victoria                      34 
Table 22   How deteriorating phases end 
Phase end reason Overnight admitted Not admitted overnight 
VIC % All Services % VIC % All Services % 
Phase change                        845  74.8  4595  69.7  1318  68.4  2304  52.6 
Discharge/case closure               65   5.8   844  12.8   273  14.2  1366  31.2 
Died                                204  18.1  1110  16.8   335  17.4   679  15.5 
Bereavement phase end                15   1.3    37   0.6     0   0.0     4   0.1 
Not stated/inadequately described     0   0.0     9   0.1     0   0.0    30   0.7 
Total  1129 100.0  6595 100.0  1926 100.0  4383 100.0 
 
 
 
Figure 11   Deteriorating phase progression - overnight admitted 
 
 
Figure 12   Deteriorating phase progression - not admitted overnight 
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Table 23   How terminal phases end 
Phase end reason Overnight admitted Not admitted overnight 
VIC % All Services % VIC % All Services % 
Phase change                        106  14.1   480  11.8   140  32.6   224  21.6 
Discharge/case closure                6   0.8    75   1.8    24   5.6    75   7.2 
Died                                570  75.6  3416  83.6   263  61.3   724  69.9 
Bereavement phase end                72   9.5   106   2.6     1   0.2     6   0.6 
Not stated/inadequately described     0   0.0     7   0.2     1   0.2     7   0.7 
Total   754 100.0  4084 100.0   429 100.0  1036 100.0 
 
 
 
 
Figure 13   Terminal phase progression - overnight admitted 
 
 
Figure 14   Terminal phase progression - not admitted overnight  
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Appendix A – Summary of data included in this report 
 
A1 – Data Summary 
 
This report includes data from a total of 100  services, 22 of which were from VIC. During the reporting period, data were provided for a total of 13885 patients who 
between them had 17394 episodes of care and 38363 palliative care phases. These total numbers are determined by a data scoping method. This method looks at the 
phase level data first and includes all phases that ended within the current reporting period. The associated episodes and patients are then determined (Section A3 
contains a more detailed explanation of this process). Table 24 shows the number of patients, episodes and phases included in this report – both for VIC and nationally. 
 
A consequence of the data scoping method is that it is likely that not all phases related to a particular episode are included in this report. Hence, the average number of 
phases per episode calculation shown in Table 24 may be an underestimate (due to episodes that cross-over 2 or more reporting periods) as it only includes phases that 
ended within the current reporting period. 
 
 
Table 24   Number and percentage of patients, episodes and phases - by episode type 
Episode Type 
  
Overnight admitted Not admitted overnight Total 
VIC All Services VIC All Services VIC All Services 
Number of patients* 1639     8890     2723     5750 4261 13885 
Number of episodes 1839    10500     3334     6894 5173 17394 
Number of phases 5023    26523     6227    11840 11250 38363 
Percentage of patients* 38.5     64.0     63.9     41.4 100 100 
Percentage of episodes 35.5     60.4     64.5     39.6 100 100 
Percentage of phases 44.6     69.1     55.4     30.9 100 100 
Average number of  phases per episode** 2.6           2.4      1.9           1.7        2.1      2.1 
*     Patients seen in both an overnight admitted and not admitted overnight setting are only counted once in the total column and hence numbers/percentages may not add to the total. 
**    Average number of phases per episode is only calculated for closed episodes and excludes bereavement phases.  
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A2 – Data Item Completion 
 
Overall, the quality of data submitted to PCOC is very good and, as shown in Tables 25, 26 and 27 below, the rate of data completion is very high.  In reviewing this table, 
it is important to note that in some cases some data items are not required to be completed. For example, place of death is only required for non-admitted patients who 
have died. Hence the complete column in the following tables only refers to the percentage of complete records where the data item was relevant.    
 
PCOC strongly encourages services to complete and submit the whole data set on every patient as non-completion may result in services being excluded from relevant 
benchmarking activities or erroneous conclusions being drawn. Low completion of data items may also distort percentages and tables in some sections. 
  
Table 25   Item completion- patient level 
Data item % Complete 
 VIC All Services 
Date of birth    100.0    100.0 
Sex    100.0     99.9 
Indigenous status     91.9     94.8 
Country of birth     90.0     94.1 
Main language     86.8     91.5 
Primary diagnosis     99.5     98.6 
 
Table 26   Item completion- episode level 
Data item % Complete 
 VIC All Services 
Date of first contact/assessment     99.9     96.2 
Referral date     99.8     92.3 
Referral source     91.6     95.1 
Episode start date    100.0    100.0 
Mode of episode start    100.0     99.0 
Accommodation at episode start     96.6     97.4 
Episode end date    100.0     99.9 
Level of support at episode start     99.5     82.9 
Mode of episode end     98.8     98.1 
Accommodation at episode end     78.5     88.1 
Level of support at episode end     99.0     97.1 
Place of death     92.3     91.1 
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Table 27   Item completion  - phase level 
Data item Sub-Category  % Complete 
 (where applicable) VIC All Services 
Phase start date  -    100.0    100.0 
Phase  -    100.0    100.0 
RUG-ADL  
at phase start   
  
Bed Mobility     91.5     95.2 
Toileting     91.6     95.1 
Transfers     91.5     95.0 
Eating     91.3     94.4 
PC Problem Severity  
at phase start   
  
Pain     97.5     79.1 
Other Symptom     95.9     83.1 
Psychological/Spiritual     97.3     92.8 
Family/Carer     97.2     91.6 
Symptom Assessment 
Score  
at phase start   
  
  
  
  
Insomnia     78.0     86.7 
Appetite     87.1     89.2 
Nausea     86.7     89.5 
Bowels     85.1     88.9 
Breathing     86.5     89.5 
Fatigue     87.7     89.7 
Pain     88.0     90.0 
Phase end reason  -    100.0     99.5 
Karnofsky at phase start  -     97.8     96.1 
 
 
Some tables throughout this report may be incomplete. 
This is because some items may not be applicable or it 
may be due to data quality issues. 
 
Please use the following key when interpreting the 
tables: 
 
na   The item is not applicable 
u  The item was unavailable/unable to be calculated due       
to missing or invalid data. 
 
In addition, interpret all figures carefully as results may 
appear distorted due to low frequencies being 
represented as percentages. 
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A3 – Data scoping methodology 
 
The method used to determine which data is included in a PCOC report looks at the phase level records first. All phase records that end
 
 within the 6 month reporting 
period are deemed to be “in scope” and would be included in the report. The episode and patient records associated with these phases are also deemed to be “in scope” 
and hence would also be included in the report. 
Figure 15 below displays four examples to help visualize this process. 
 
Figure 15   Diagram of the PCOC data scoping process 
 
 
In Example 1
 
, the patient (represented by the green line) has one episode (represented by the blue line). This episode has six phases (represented by the purple line 
segments). All six phases would be included in the report as they all end within the reporting period. Hence, the episode and patient would also be in the report. 
In Example 2
 
, the patient has two episodes - the first having six phases and the second having seven phases. Looking at the phases associated with the first episode, the 
last four will be included in the report (as they end within the reporting period). For the phases relating to the second episode, only the first three end within the period, 
so only these would be included in the report. Both of the episode records and the patient record would also be reported on. 
In Example 3
 
, the patient has one episode and five phases. Only the last three phases will be reported on as they are the only ones ending within the reporting period. 
The episode and patient records would be included in the report. 
In Example 4, the patient again has one episode and five phases. This time, only the first three phases will be included in the report. Again, the episode and patient 
records would be included in the report on as they have associated phases ending within the period. 
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Appendix B – Benchmark Notes 
 
B1 – Outline of Benchmark Measures and Targets 
 
There is strong sectoral support for national benchmarks and a consensus that such benchmarks can drive service innovation regardless of model of care. Benchmarking 
provides opportunities to understand the services that are provided, the outcomes patients experience and also to generate research opportunities focused on how to 
demonstrate variations in practice and outcomes. 
Beginning in the reporting period January to June 2009 (Report 7), PCOC introduced four benchmark measures into the routine PCOC reports: 
 
Measure Benchmark 
1. Time from referral to first contact   
  
90% of patients are contacted on the day of, or the day after referral 
 
2. Time in unstable phase 85% in their first phase remain unstable for less than 7 days 
90% in a subsequent phase remain unstable for less than 7 days 
The median time in unstable phase is 2 days or less 
3. Change in pain (both PCPSS and SAS) 90% of phases that start with absent/mild pain start pain have absent/mild end pain 
60% of phases  with moderate/severe start pain have absent/mild end pain 
 
4. Change in symptoms relative to the national average
  (8 symptoms are included) 
A score of 0 or above 
 
 
 
 
It is recognised that services aspire to achieve best practice, and to reflect this, current benchmarks have intentionally been set at a high level. Where a service does not 
meet the benchmark, PCOC has adopted a target of improvement of 10% per year.  Discussion with your PCOC Quality Improvement Facilitator (QIF) can assist services 
to identify areas where improvements can be made.  The PCOC Quality Improvement Facilitators (QIFs) can assist services to identify areas where improvements can be 
made.   
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B2 – National profile graphs 
 
In each national profile graph, the shaded reqion describes the national profile for that benchmark. VIC services are highlighted as dots on the graph. Graphs may have 
differing numbers of dots, caused by services not qualifying for inclusion in a particular benchmark. This may be caused by insufficient data item completion, or services 
not having any records falling into a particular category, for example, no phases starting with moderate/severe SAS pain. 
 
B3 – X-CAS technical notes 
 
The procedure for calculating X-CAS is as follows: 
 
Step 1. Using the baseline data, calculate the average change in symptom for all patients
Step 2. For each individual phase, calculate the change in symptom score (start score minus end score) 
 in the same phase, having the same symptom start score. This is 
 called the expected change. 
Step 3. For each individual phase, calculate the difference between their change in symptom score
Step 4. Average all of the values calculated in step 3  to produce the Symptom Casemix-Adjusted Score (e.g. PCAS) 
 (calculated in step 2) and the relevant expected change 
 (calculated in step 1).  
 
 
Example: 
Phase PCPSS Pain  
at start 
PCPSS Pain  
at end 
Step 1: Expected PCPSS Pain change 
(from Report 6 National Database) 
Step2: PCPSS Pain change 
(start score minus end score) 
Step 3: Difference 
(Step 2 minus Step 1) 
Step 4: Average of 
values in step 3 
Stable 0 1 -0.8 -1 -0.2  
(-0.2+0.9+0.4-0.4) 
  = 0.175 
4 
Stable 1 1 -0.9 0 0.9 
Unstable 3 1 1.6 2 0.4 
Deteriorating 2 1 1.4 1 -0.4 
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